3243-41-2

Usage

Drug class

Nonsteroidal anti-inflammatory drug (NSAID)

Use

Relieves pain and reduces inflammation in conditions such as arthritis and menstrual cramps

Mechanism of action

Inhibits the production of prostaglandins

Chemical structure

Propanoic acid backbone with a butoxyphenyl group attached at the third position

Metabolism

Metabolized in the liver and excreted in the urine

Side effects

Stomach upset, nausea, dizziness

Form

Oral tablets or capsules

Administration

Usually taken with food to minimize stomach irritation

Caution

Should be used under the guidance of a healthcare professional due to potential interactions with other medications and potential risks for people with certain medical conditions

Upstream product

• 55379-96-9 4-butoxycinnamic acid 
• 2417-74-5 4-butoxybenzyl bromide 
• 105-53-3 diethyl malonate 
• 109-65-9 1-bromo-butane 
• 501-97-3 4-hydroxyphenylpropionic acid 
• 6214-45-5 (4-butoxyphenyl)methanol 
• 5736-88-9 p-butoxybenzaldehyde 

Downstream Products

• 125567-55-7 3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-propionamide 
• 115514-10-8 methyl 3-(4-butyloxyphenyl)propanoate 
• 100999-18-6 3-(4-butoxy-phenyl)-propionyl chloride 
• 89790-07-8 3-(p-butoxyphenyl)propionohydrazine 
• 89790-08-9 3-(4-Butoxy-phenyl)-propionamide 

Relevant academic research and scientific papers

PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS

The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.

Design of Inhibitors from the Three-Dimensional Structure of Alcohol Dehydrogenase. Chemical Synthesis and Enzymatic Properties

Inhibitors of liver alcohol dehydrogenase were designed from the three-dimensional structure of the enzyme.The ligand to the catalytic zinc ion is an amide group or, better, a formamide group.With the latter function, a hydrogen bond between the NH group and the hydroxyl group of Ser-48 may be formed.The hydrophobic substrate binding site brings structural restraints. α-ω bifunctional molecules show good inhibitory properties possibly due to the interactions with polar residues at the entrance of the substrate binding site.